不活化ポリオ・狂犬病ワクチンの世界市場レポート 2025年

不活化ポリオ・狂犬病ワクチン市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.8％で28億8,000万米ドルに成長します。予測期間中の成長は、ワクチン技術の進歩、新興市場におけるワクチン接種需要の高まり、世界の健康安全保障への関心の高まり、ワクチン接種を奨励する政府の政策、予防対策へのヘルスケア支出の増加などからもたらされると予想されます。予測期間中の主な動向としては、ポリオと狂犬病の混合ワクチンの需要拡大、ワクチンの安定性を高めるための凍結乾燥技術の進歩、投与を容易にするための単回投与製剤の開発、より良いワクチン流通のためのコールドチェーンロジスティクスの改善、世界の予防接種プログラムの拡大、政府出資の予防接種イニシアチブなどが挙げられます。

効果的な予防接種プログラムに対する需要の高まりが、不活化ポリオ・狂犬病ワクチン市場の成長を牽引すると予想されます。疾病から人々を守るために政府や団体によって組織される予防接種プログラムは、疾病の発生を予防し、ヘルスケアコストを削減し、公衆衛生を向上させるために政府が取り組みを強化するにつれて、より広まりつつあります。このようなイニシアチブは、認知度の向上、資金の確保、リスクの高い地域での適用範囲の拡大により、不活化ポリオ・狂犬病ワクチンの需要に貢献しています。多くの場合、政府や保健機関が主導する集団予防接種キャンペーンや定期予防接種は、ワクチンの安定的な摂取を保証します。例えば、2024年4月、汎米保健機構（PAHO）は、「あなたの未来を守るため、今すぐGetVaxに参加しましょう」をテーマとした第22回南北アメリカ予防接種週間（VWA）が、6,500万回以上の接種を実施し、十分なサービスを受けていない地域での接種率を高めることを目的としたものであったと報告しました。このイニシアティブはまた、誤った情報と闘い、地域社会との関わりやニーズに合わせたキャンペーンを通じてワクチンへのアクセスを改善することにも努めました。このような効果的なワクチン接種プログラムに対する需要の高まりが、不活化ポリオ・狂犬病ワクチン市場の成長を牽引しています。

不活化ポリオ・狂犬病ワクチン市場の各社は、免疫原性を改善し、効果的な疾病予防に対する世界の需要に対応するため、不活化狂犬病ワクチンなどの製品開発を進めています。キルドウイルス狂犬病ワクチンは、化学的または物理的処理によって感染性を失った狂犬病ウイルスを使用して製造されます。これらのワクチンは、病気を引き起こすことなく免疫系を刺激して防御抗体を産生させるため、曝露前と曝露後の両方に安全かつ効果的に使用できます。例えば、2024年4月、英国を拠点とする製薬会社サノフィは、不活化狂犬病ワクチンVerorabを、すべての年齢層を対象とした狂犬病の曝露前および曝露後の予防のために英国で発売しました。1万3,000人以上から得られた広範な臨床データに基づいて英国で承認されたこのワクチンは、80カ国以上で広く使用されています。ベロラボは、高リスク国への渡航者や狂犬病曝露後治療に効果的な予防接種の選択肢を提供し、臨床試験では強力な免疫反応と長期にわたる予防効果が示されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界不活化ポリオ・狂犬病ワクチンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の不活化ポリオ・狂犬病ワクチン市場：成長率分析
• 世界の不活化ポリオ・狂犬病ワクチン市場の実績：規模と成長、2019～2024年
• 世界の不活化ポリオ・狂犬病ワクチン市場の予測：規模と成長、2024～2029年、2034年
• 世界不活化ポリオ・狂犬病ワクチン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の不活化ポリオ・狂犬病ワクチン市場：製品タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 不活化ポリオワクチン
• 不活化狂犬病ワクチン
• 世界の不活化ポリオ・狂犬病ワクチン市場：不活化法別、実績と予測、2019～2024年、2024～2029年、2034年
• 溶剤洗剤法
• 放射線法
• pH濃度
• 加熱不活化
• その他の不活化方法
• 世界の不活化ポリオ・狂犬病ワクチン市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 政府
• 民間
• 世界の不活化ポリオ・狂犬病ワクチン市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 小児
• 大人
• 世界の不活化ポリオ・狂犬病ワクチン市場：不活化ポリオワクチンの種類別、実績と予測、2019～2024年、2024～2029年、2034年
• 注射用不活化ポリオワクチン
• 経口不活化ポリオワクチン
• 世界の不活化ポリオ・狂犬病ワクチン市場：不活化狂犬病ワクチンの種類別、実績と予測、2019～2024年、2024～2029年、2034年
• 注射用不活化狂犬病ワクチン
• 皮内不活化狂犬病ワクチン

第7章 地域別・国別分析

• 世界の不活化ポリオ・狂犬病ワクチン市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の不活化ポリオ・狂犬病ワクチン市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 不活化ポリオ・狂犬病ワクチン市場：競合情勢
• 不活化ポリオ・狂犬病ワクチン市場：企業プロファイル
  • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • LG Chem Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Sinovac Biotech Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Zoetis Inc.
• Cadila Pharmaceuticals
• Zydus Lifesciences Limited
• Biological E. Limited
• Serum Institute of India（SII）
• Indian Immunologicals Limited（IIL）
• Instituto Butantan
• Valneva SE
• Bio Farma
• Bharat Biotech
• Bilthoven Biologicals
• Panacea Biotec
• Batavia Biosciences
• Hilleman Laboratories
• China National Pharmaceutical Group Co Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 不活化ポリオ・狂犬病ワクチン市場、2029年：新たな機会を提供する国
• 不活化ポリオ・狂犬病ワクチン市場、2029年：新たな機会を提供するセグメント
• 不活化ポリオ・狂犬病ワクチン市場、2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Inactivated polio and rabies vaccines (IPV) are designed to protect individuals from polio and rabies, respectively. Both vaccines are made using viruses that have been inactivated, meaning they cannot cause disease. IPV prevents poliomyelitis, a viral illness that can lead to paralysis, while the inactivated rabies vaccine offers protection against rabies, a fatal infection usually transmitted through animal bites. These vaccines stimulate the immune system to provide long-lasting protection without causing illness.

The primary product types of inactivated polio and rabies vaccines include the inactivated polio vaccine and inactivated rabies vaccine. The inactivated polio vaccine (IPV) is a safe, injectable vaccine derived from inactivated poliovirus, designed to strengthen immunity and protect against polio without causing infection. It is inactivated using various methods, such as the solvent-detergent method, radiation, pH concentration, heat inactivation, and others. The vaccine is distributed through several channels, including both government and private sectors, for use in different populations, such as pediatrics and adults.

The inactivated polio and rabies vaccines market research report is one of a series of new reports from The Business Research Company that provides inactivated polio and rabies vaccines market statistics, including the inactivated polio and rabies vaccines industry global market size, regional shares, competitors with the inactivated polio and rabies vaccines market share, detailed inactivated polio and rabies vaccines market segments, market trends, opportunities, and any further data you may need to thrive in the inactivated polio and rabies vaccines industry. This inactivated polio and rabies vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The inactivated polio and rabies vaccines market size has grown strongly in recent years. It will grow from $2.16 billion in 2024 to $2.30 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth during the historic period can be attributed to factors such as expanding vaccination campaigns, increased awareness about polio and rabies, government immunization programs, high incidence rates of polio and rabies in certain regions, and support from international health organizations.

The inactivated polio and rabies vaccines market size is expected to see strong growth in the next few years. It will grow to $2.88 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth during the forecast period is expected to result from advancements in vaccine technology, the rising demand for vaccination in emerging markets, a heightened focus on global health security, government policies encouraging vaccination, and increased healthcare spending on preventive measures. Major trends during the forecast period include a growing demand for combined polio and rabies vaccines, advancements in freeze-drying technology to enhance vaccine stability, the development of single-dose formulations for easier administration, improvements in cold chain logistics for better vaccine distribution, expansion of global immunization programs, and government-funded vaccination initiatives.

The increasing demand for effective vaccination programs is expected to drive the growth of the inactivated polio and rabies vaccines market. Vaccination programs, organized by governments or organizations to protect people from diseases, are becoming more widespread as governments intensify efforts to prevent outbreaks, reduce healthcare costs, and improve public health. These initiatives contribute to the demand for inactivated polio and rabies vaccines by raising awareness, securing funding, and expanding coverage in high-risk areas. Mass vaccination campaigns and routine immunizations, often led by governments and health organizations, ensure consistent vaccine uptake. For example, in April 2024, the Pan American Health Organization (PAHO) reported that the 22nd Vaccination Week in the Americas (VWA), themed "Engage now to protect your future, GetVax," aimed to boost vaccination coverage in underserved areas by administering over 65 million doses. The initiative also worked to combat misinformation and improve vaccine access through community engagement and tailored campaigns. This growing demand for effective vaccination programs is driving the growth of the inactivated polio and rabies vaccines market.

Companies in the inactivated polio and rabies vaccines market are advancing product development, such as inactivated rabies vaccines, to improve immunogenicity and address the global demand for effective disease prevention. Killed virus rabies vaccines are made using a rabies virus that has been rendered non-infectious through chemical or physical processes. These vaccines stimulate the immune system to produce protective antibodies without causing the disease, making them safe and effective for both pre- and post-exposure use. For example, in April 2024, Sanofi, a UK-based pharmaceutical company, launched Verorab, an inactivated rabies vaccine, in the UK for both pre-exposure and post-exposure prophylaxis of rabies for all age groups. The vaccine, approved in the UK based on extensive clinical data from over 13,000 individuals, has been widely used in over 80 countries. Verorab offers an effective immunization option for travelers to high-risk countries and for rabies post-exposure treatment, with clinical trials showing strong immune responses and long-lasting protection.

In June 2024, Sanofi partnered with Biovac, a South Africa-based biopharmaceutical company, to support local vaccine production in Africa. This collaboration aims to establish sustainable local manufacturing of inactivated polio vaccines (IPV), enhancing regional self-sufficiency and advancing polio eradication efforts across more than 40 African countries. Biovac specializes in developing vaccines for diseases that disproportionately affect people in Africa.

Major players in the inactivated polio and rabies vaccines market are Merck & Co Inc., Sanofi S.A., LG Chem Ltd., Boehringer Ingelheim International GmbH, Sinovac Biotech, Zoetis Inc., Cadila Pharmaceuticals, Zydus Lifesciences Limited, Biological E. Limited, Serum Institute of India (SII), Indian Immunologicals Limited (IIL), Instituto Butantan, Valneva SE, Bio Farma, Bharat Biotech, Bilthoven Biologicals, Panacea Biotec, Batavia Biosciences, Hilleman Laboratories, and China National Pharmaceutical Group Co Ltd.

North America was the largest region in the inactivated polio and rabies vaccines market in 2024. The regions covered in inactivated polio and rabies vaccines report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the inactivated polio and rabies vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The inactivated polio and rabies vaccines market consists of sales of combination vaccines containing inactivated polio vaccine (IPV), pre-exposure prophylaxis vaccines, and post-exposure prophylaxis (PEP) kits. Values in this market are 'factory gate' values, that is, the value of goods sold to the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Inactivated Polio And Rabies Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on inactivated polio and rabies vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for inactivated polio and rabies vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The inactivated polio and rabies vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Inactivated Polio Vaccine; Inactivated Rabies Vaccine
• 2) By Method Of Inactivation: Solvent Detergent Method; Radiation Method; pH Concentration; Heat Inactivation; Other Method Of Inactivations
• 3) By Distribution Channel: Government; Private
• 4) By Application: Pediatrics; Adults
• Subsegments:
• 1) By Inactivated Polio Vaccine: Injectable Inactivated Polio Vaccine; Oral Inactivated Polio Vaccine
• 2) By Inactivated Rabies Vaccine: Injectable Inactivated Rabies Vaccine; Intradermal Inactivated Rabies Vaccine
• Companies Mentioned: Merck & Co Inc.; Sanofi S.A.; LG Chem Ltd.; Boehringer Ingelheim International GmbH; Sinovac Biotech
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Inactivated Polio And Rabies Vaccines Market Characteristics

3. Inactivated Polio And Rabies Vaccines Market Trends And Strategies

4. Inactivated Polio And Rabies Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Inactivated Polio And Rabies Vaccines Growth Analysis And Strategic Analysis Framework

• 5.1. Global Inactivated Polio And Rabies Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Inactivated Polio And Rabies Vaccines Market Growth Rate Analysis
• 5.4. Global Inactivated Polio And Rabies Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Inactivated Polio And Rabies Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Inactivated Polio And Rabies Vaccines Total Addressable Market (TAM)

6. Inactivated Polio And Rabies Vaccines Market Segmentation

• 6.1. Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated Polio Vaccine
• Inactivated Rabies Vaccine
• 6.2. Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Solvent Detergent Method
• Radiation Method
• pH Concentration
• Heat Inactivation
• Other Method Of Inactivations
• 6.3. Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Government
• Private
• 6.4. Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatrics
• Adults
• 6.5. Global Inactivated Polio And Rabies Vaccines Market, Sub-Segmentation Of Inactivated Polio Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Inactivated Polio Vaccine
• Oral Inactivated Polio Vaccine
• 6.6. Global Inactivated Polio And Rabies Vaccines Market, Sub-Segmentation Of Inactivated Rabies Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Inactivated Rabies Vaccine
• Intradermal Inactivated Rabies Vaccine

7. Inactivated Polio And Rabies Vaccines Market Regional And Country Analysis

• 7.1. Global Inactivated Polio And Rabies Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Inactivated Polio And Rabies Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Inactivated Polio And Rabies Vaccines Market

• 8.1. Asia-Pacific Inactivated Polio And Rabies Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Inactivated Polio And Rabies Vaccines Market

• 9.1. China Inactivated Polio And Rabies Vaccines Market Overview
• 9.2. China Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Inactivated Polio And Rabies Vaccines Market

• 10.1. India Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Inactivated Polio And Rabies Vaccines Market

• 11.1. Japan Inactivated Polio And Rabies Vaccines Market Overview
• 11.2. Japan Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Inactivated Polio And Rabies Vaccines Market

• 12.1. Australia Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Inactivated Polio And Rabies Vaccines Market

• 13.1. Indonesia Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Inactivated Polio And Rabies Vaccines Market

• 14.1. South Korea Inactivated Polio And Rabies Vaccines Market Overview
• 14.2. South Korea Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Inactivated Polio And Rabies Vaccines Market

• 15.1. Western Europe Inactivated Polio And Rabies Vaccines Market Overview
• 15.2. Western Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Inactivated Polio And Rabies Vaccines Market

• 16.1. UK Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Inactivated Polio And Rabies Vaccines Market

• 17.1. Germany Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Inactivated Polio And Rabies Vaccines Market

• 18.1. France Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Inactivated Polio And Rabies Vaccines Market

• 19.1. Italy Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Inactivated Polio And Rabies Vaccines Market

• 20.1. Spain Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Inactivated Polio And Rabies Vaccines Market

• 21.1. Eastern Europe Inactivated Polio And Rabies Vaccines Market Overview
• 21.2. Eastern Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Inactivated Polio And Rabies Vaccines Market

• 22.1. Russia Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Inactivated Polio And Rabies Vaccines Market

• 23.1. North America Inactivated Polio And Rabies Vaccines Market Overview
• 23.2. North America Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Inactivated Polio And Rabies Vaccines Market

• 24.1. USA Inactivated Polio And Rabies Vaccines Market Overview
• 24.2. USA Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Inactivated Polio And Rabies Vaccines Market

• 25.1. Canada Inactivated Polio And Rabies Vaccines Market Overview
• 25.2. Canada Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Inactivated Polio And Rabies Vaccines Market

• 26.1. South America Inactivated Polio And Rabies Vaccines Market Overview
• 26.2. South America Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Inactivated Polio And Rabies Vaccines Market

• 27.1. Brazil Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Inactivated Polio And Rabies Vaccines Market

• 28.1. Middle East Inactivated Polio And Rabies Vaccines Market Overview
• 28.2. Middle East Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Inactivated Polio And Rabies Vaccines Market

• 29.1. Africa Inactivated Polio And Rabies Vaccines Market Overview
• 29.2. Africa Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Inactivated Polio And Rabies Vaccines Market Competitive Landscape And Company Profiles

• 30.1. Inactivated Polio And Rabies Vaccines Market Competitive Landscape
• 30.2. Inactivated Polio And Rabies Vaccines Market Company Profiles
  • 30.2.1. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. LG Chem Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sinovac Biotech Overview, Products and Services, Strategy and Financial Analysis

31. Inactivated Polio And Rabies Vaccines Market Other Major And Innovative Companies

• 31.1. Zoetis Inc.
• 31.2. Cadila Pharmaceuticals
• 31.3. Zydus Lifesciences Limited
• 31.4. Biological E. Limited
• 31.5. Serum Institute of India (SII)
• 31.6. Indian Immunologicals Limited (IIL)
• 31.7. Instituto Butantan
• 31.8. Valneva SE
• 31.9. Bio Farma
• 31.10. Bharat Biotech
• 31.11. Bilthoven Biologicals
• 31.12. Panacea Biotec
• 31.13. Batavia Biosciences
• 31.14. Hilleman Laboratories
• 31.15. China National Pharmaceutical Group Co Ltd.

32. Global Inactivated Polio And Rabies Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Inactivated Polio And Rabies Vaccines Market

34. Recent Developments In The Inactivated Polio And Rabies Vaccines Market

35. Inactivated Polio And Rabies Vaccines Market High Potential Countries, Segments and Strategies

• 35.1 Inactivated Polio And Rabies Vaccines Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Inactivated Polio And Rabies Vaccines Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Inactivated Polio And Rabies Vaccines Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer